ACUTUS MEDICAL INC (AFIB) Stock Price, Quote, News and Overview
NASDAQ:AFIB - Nasdaq - US0051111096 - Common Stock - Currency: USD
AFIB Quote, Performance and Key Statistics
0.09
-0.03 (-26.83%)
The current stock price of AFIB is 0.09 USD. In the past month the price decreased by -45.05%. In the past year, price decreased by -89.69%.
AFIB Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About AFIB
Company Profile
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 225 full-time employees. The company went IPO on 2020-08-06. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The firm's product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.
Company Info
ACUTUS MEDICAL INC
2210 Faraday Ave Ste 100
Carlsbad CALIFORNIA 92008 US
CEO: Vince Burgess
Employees: 225
Company Website: https://www.acutusmedical.com/us
Phone: 14422326144
ACUTUS MEDICAL INC / AFIB FAQ
What is the stock price of ACUTUS MEDICAL INC today?
The current stock price of AFIB is 0.09 USD. The price decreased by -26.83% in the last trading session.
What is the ticker symbol for ACUTUS MEDICAL INC stock?
The exchange symbol of ACUTUS MEDICAL INC is AFIB and it is listed on the Nasdaq exchange.
On which exchange is AFIB stock listed?
AFIB stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ACUTUS MEDICAL INC stock?
6 analysts have analysed AFIB and the average price target is 1.53 USD. This implies a price increase of 1600% is expected in the next year compared to the current price of 0.09. Check the ACUTUS MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ACUTUS MEDICAL INC worth?
ACUTUS MEDICAL INC (AFIB) has a market capitalization of 2.67M USD. This makes AFIB a Nano Cap stock.
How many employees does ACUTUS MEDICAL INC have?
ACUTUS MEDICAL INC (AFIB) currently has 225 employees.
Is ACUTUS MEDICAL INC (AFIB) expected to grow?
The Revenue of ACUTUS MEDICAL INC (AFIB) is expected to grow by 31.1% in the next year. Check the estimates tab for more information on the AFIB EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ACUTUS MEDICAL INC (AFIB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AFIB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AFIB, evaluating the profitability, health, valuation and growth aspects
- ACUTUS MEDICAL INC (AFIB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACUTUS MEDICAL INC (AFIB) Sales and EPS estimates to see what analysts future expectations are.
- ACUTUS MEDICAL INC (AFIB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACUTUS MEDICAL INC (AFIB) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACUTUS MEDICAL INC (AFIB) Stock Chart to make your own analysis
- ACUTUS MEDICAL INC (AFIB) Latest news and press-releases to stay up to date.
Does ACUTUS MEDICAL INC (AFIB) stock pay dividends?
AFIB does not pay a dividend.
When does ACUTUS MEDICAL INC (AFIB) report earnings?
ACUTUS MEDICAL INC (AFIB) will report earnings on 2024-08-05, after the market close.
What is the Price/Earnings (PE) ratio of ACUTUS MEDICAL INC (AFIB)?
ACUTUS MEDICAL INC (AFIB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.69).
What is the Short Interest ratio of ACUTUS MEDICAL INC (AFIB) stock?
The outstanding short interest for ACUTUS MEDICAL INC (AFIB) is 0.1% of its float. Check the ownership tab for more information on the AFIB short interest.
AFIB Technical Analysis
AFIB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AFIB. Both the profitability and financial health of AFIB have multiple concerns.
AFIB Financial Highlights
Over the last trailing twelve months AFIB reported a non-GAAP Earnings per Share(EPS) of -2.69. The EPS increased by 34.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -111.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AFIB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to AFIB. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 12.16% and a revenue growth 31.1% for AFIB